Supernus Pharmaceuticals (SUPN) Cash from Discontinued Operations (2011)
Supernus Pharmaceuticals (SUPN) reported Cash from Discontinued Operations of 120000.0 for Q4 2011, down 109.18% quarter-over-quarter from 1307000.0 in Q3 2011.
Supernus Pharmaceuticals (SUPN) Cash from Discontinued Operations (2011) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 1 years of Cash from Discontinued Operations data on file, last reported at 120000.0 in Q4 2011.
- Cash from Discontinued Operations for Q4 2011 came in at 120000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2011 was 2021000.0 (changed N/A YoY), and the FY2011 annual result was 2021000.0, up 674.15% from the prior year.
- Cash from Discontinued Operations retreated to 120000.0 in Q4 2011 per SUPN's latest filing, from 1307000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 1749000.0 in Q1 2011 and troughed at 915000.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discont. Ops (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -120,000.00 |
| Dec 31, 2011 | -120,000.00 |
| Sep 30, 2011 | 1.31 Mn |
| Sep 30, 2011 | 1.31 Mn |
| Jun 30, 2011 | -915,000.00 |
| Jun 30, 2011 | -915,000.00 |
| Mar 31, 2011 | 1.75 Mn |
| Mar 31, 2011 | 1.75 Mn |